Vickie S. Reed - 13 May 2021 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Vickie S. Reed
Issuer symbol
EVOK
Transactions as of
13 May 2021
Net transactions value
$0
Form type
4
Filing time
17 May 2021, 21:05:03 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +70,000 $0.000000 70,000 13 May 2021 Common Stock 70,000 $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 13, 2021 and shall vest in equal yearly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.